643 results
Page 10 of 33
424B5
p4qcfp 05z
31 Oct 13
Prospectus supplement for primary offering
12:00am
424B5
kz8 pvh7n
30 Oct 13
Prospectus supplement for primary offering
12:00am
8-K/A
7j83dobqo6z7nzls9 yn
25 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
1w3fb0kup3qrv
17 Oct 13
Regulation FD Disclosure
12:00am
8-K
EX-99.2
f3k69u19ebze
17 Oct 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
8pwad
17 Oct 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
x4c1vy ha
4 Oct 13
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications
12:00am
8-K
1qdp8xa
4 Oct 13
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications
12:00am
8-K/A
EX-4.1
zd1gmb
14 Jun 13
Financial Statements and Exhibits
12:00am
8-K/A
cgtpvfzjap4ov m84
14 Jun 13
Financial Statements and Exhibits
12:00am
8-K
f0jshpqv7id4tq6q2orx
10 Jun 13
Discovery Labs Responds to FDA Request for Clarification of Recently
12:00am
8-K
EX-99.1
vnylu cuvc
10 Jun 13
Discovery Labs Responds to FDA Request for Clarification of Recently
12:00am
424B5
vcrh03dgqzo1r980zf
9 May 13
Prospectus supplement for primary offering
12:00am
8-K
wcmxy0sd9gq8tu rfo3
7 May 13
Discovery Labs Reports First Quarter 2013 Financial Results
12:00am
8-K
EX-99.1
te9z 6uq0yo9zp
7 May 13
Discovery Labs Reports First Quarter 2013 Financial Results
12:00am
8-K
jc5 a0s4xcmqlw74t
15 Apr 13
Other Events
12:00am